Phio Pharmaceuticals Corp. (PHIO)
1.14
-0.03
(-2.56%)
USD |
NASDAQ |
Dec 11, 16:00
1.15
+0.01
(+0.88%)
Pre-Market: 08:59
Phio Pharmaceuticals Cash from Investing (Quarterly): -0.007M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Tharimmune, Inc. | 0.00 |
| NovaBay Pharmaceuticals, Inc. | 0.00 |
| Palatin Technologies, Inc. | 0.00 |
| Theriva Biologics, Inc. | -0.019M |
| Oragenics, Inc. | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -2.085M |
| Cash from Financing (Quarterly) | 2.022M |
| Free Cash Flow | -7.284M |
| Free Cash Flow Per Share (Quarterly) | -0.3825 |
| Free Cash Flow to Equity (Quarterly) | -2.092M |
| Free Cash Flow to Firm (Quarterly) | -2.092M |
| Free Cash Flow Yield | -156.8% |